Cargando…
Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808068/ https://www.ncbi.nlm.nih.gov/pubmed/28990581 http://dx.doi.org/10.1038/leu.2017.306 |
| _version_ | 1783299393392214016 |
|---|---|
| author | Topp, M S Stelljes, M Zugmaier, G Barnette, P Heffner, L T Trippett, T Duell, J Bargou, R C Holland, C Benjamin, J E Klinger, M Litzow, M R |
| author_facet | Topp, M S Stelljes, M Zugmaier, G Barnette, P Heffner, L T Trippett, T Duell, J Bargou, R C Holland, C Benjamin, J E Klinger, M Litzow, M R |
| author_sort | Topp, M S |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5808068 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58080682018-02-14 Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia Topp, M S Stelljes, M Zugmaier, G Barnette, P Heffner, L T Trippett, T Duell, J Bargou, R C Holland, C Benjamin, J E Klinger, M Litzow, M R Leukemia Letter to the Editor Nature Publishing Group 2018-02 2017-10-31 /pmc/articles/PMC5808068/ /pubmed/28990581 http://dx.doi.org/10.1038/leu.2017.306 Text en Copyright © 2018 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Letter to the Editor Topp, M S Stelljes, M Zugmaier, G Barnette, P Heffner, L T Trippett, T Duell, J Bargou, R C Holland, C Benjamin, J E Klinger, M Litzow, M R Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia |
| title | Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia |
| title_full | Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia |
| title_fullStr | Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia |
| title_full_unstemmed | Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia |
| title_short | Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia |
| title_sort | blinatumomab retreatment after relapse in patients with relapsed/refractory b-precursor acute lymphoblastic leukemia |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808068/ https://www.ncbi.nlm.nih.gov/pubmed/28990581 http://dx.doi.org/10.1038/leu.2017.306 |
| work_keys_str_mv | AT toppms blinatumomabretreatmentafterrelapseinpatientswithrelapsedrefractorybprecursoracutelymphoblasticleukemia AT stelljesm blinatumomabretreatmentafterrelapseinpatientswithrelapsedrefractorybprecursoracutelymphoblasticleukemia AT zugmaierg blinatumomabretreatmentafterrelapseinpatientswithrelapsedrefractorybprecursoracutelymphoblasticleukemia AT barnettep blinatumomabretreatmentafterrelapseinpatientswithrelapsedrefractorybprecursoracutelymphoblasticleukemia AT heffnerlt blinatumomabretreatmentafterrelapseinpatientswithrelapsedrefractorybprecursoracutelymphoblasticleukemia AT trippettt blinatumomabretreatmentafterrelapseinpatientswithrelapsedrefractorybprecursoracutelymphoblasticleukemia AT duellj blinatumomabretreatmentafterrelapseinpatientswithrelapsedrefractorybprecursoracutelymphoblasticleukemia AT bargourc blinatumomabretreatmentafterrelapseinpatientswithrelapsedrefractorybprecursoracutelymphoblasticleukemia AT hollandc blinatumomabretreatmentafterrelapseinpatientswithrelapsedrefractorybprecursoracutelymphoblasticleukemia AT benjaminje blinatumomabretreatmentafterrelapseinpatientswithrelapsedrefractorybprecursoracutelymphoblasticleukemia AT klingerm blinatumomabretreatmentafterrelapseinpatientswithrelapsedrefractorybprecursoracutelymphoblasticleukemia AT litzowmr blinatumomabretreatmentafterrelapseinpatientswithrelapsedrefractorybprecursoracutelymphoblasticleukemia |